Lawrence Karsh, MD, FACS

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    FKD
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Consultant or Advisor (General Urology)
    Ineligible company:
    Swan Valley Medical
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Vaxiion
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Investment Interest (Oncology)
    Ineligible company:
    3D Biopsy
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Nymox
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Precision Biopsy
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    OPKO
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Precision Med
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Augmenix
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Myriad Genetics
    Date added:
    Date updated:
    09/14/2023

Pages

Return to What's New in the Management of Hormone Naïve & Castrate Resistant Prostate Cancer: A Case-based Session for Urologists, Advanced Practice Providers and Teams Webcast (2021)